The legal and ethical issues that confront society due to Artificial Intelligence (AI) include privacy and surveillance, bias or discrimination, and potentially the philosophical challenge is the role of human judgment. Concerns about newer digital technologies becoming a new source of inaccuracy and data breaches have arisen as a result of its use. Mistakes in the procedure or protocol in the field of healthcare can have devastating consequences for the patient who is the victim of the error. Because patients come into contact with physicians at moments in their lives when they are most vulnerable, it is crucial to remember this. Currently, there are no well-defined regulations in place to address the legal and ethical issues that may arise due to the use of artificial intelligence in healthcare settings. This review attempts to address these pertinent issues highlighting the need for algorithmic transparency, privacy, and protection of all the beneficiaries involved and cybersecurity of associated vulnerabilities.

Lung cancer is the most common cause of cancer-related deaths in the USA. It can be detected and diagnosed using computed tomography images. For an automated classifier, identifying predictive features from medical images is a key concern. Deep feature extraction using pretrained convolutional neural networks (CNNs) has recently been successfully applied in some image domains. Here, we applied a pretrained CNN to extract deep features from 40 computed tomography images, with contrast, of non-small cell adenocarcinoma lung cancer, and combined deep features with traditional image features and trained classifiers to predict short- and long-term survivors. We experimented with several pretrained CNNs and several feature selection strategies. The best previously reported accuracy when using traditional quantitative features was 77.5% (area under the curve [AUC], 0.712), which was achieved by a decision tree classifier. The best reported accuracy from transfer learning and deep features was 77.5% (AUC, 0.713) using a decision tree classifier. When extracted deep neural network features were combined with traditional quantitative features, we obtained an accuracy of 90% (AUC, 0.935) with the 5 best post-rectified linear unit features extracted from a vgg-f pretrained CNN and the 5 best traditional features. The best results were achieved with the symmetric uncertainty feature ranking algorithm followed by a random forests classifier.

Lung cancer has a high incidence and mortality rate. Early detection and diagnosis of lung cancers is best achieved with low-dose computed tomography (CT). Classical radiomics features extracted from lung CT images have been shown as able to predict cancer incidence and prognosis. With the advancement of deep learning and convolutional neural networks (CNNs), deep features can be identified to analyze lung CTs for prognosis prediction and diagnosis. Due to a limited number of available images in the medical field, the transfer learning concept can be helpful. Using subsets of participants from the National Lung Screening Trial (NLST), we utilized a transfer learning approach to differentiate lung cancer nodules versus positive controls. We experimented with three different pretrained CNNs for extracting deep features and used five different classifiers. Experiments were also conducted with deep features from different color channels of a pretrained CNN. Selected deep features were combined with radiomics features. A CNN was designed and trained. Combinations of features from pretrained, CNNs trained on NLST data, and classical radiomics were used to build classifiers. The best accuracy (76.79%) was obtained using feature combinations. An area under the receiver operating characteristic curve of 0.87 was obtained using a CNN trained on an augmented NLST data cohort.

<p>Testing for COVID-19 has been unable to keep up with the demand. Further, the false negative rate is projected to be as high as 30% and test results can take some time to obtain. X-ray machines are widely available and provide images for diagnosis quickly. This paper explores how useful chest X-ray images can be in diagnosing COVID-19 disease. We have obtained 135 chest X-rays of COVID-19 and 320 chest X-rays of viral and bacterial pneumonia. </p><p> A pre-trained deep convolutional neural network, Resnet50 was tuned on 102 COVID-19 cases and 102 other pneumonia cases in a 10-fold cross validation. The results were </p><p> an overall accuracy of 89.2% with a COVID-19 true positive rate of 0.8039 and an AUC of 0.95. Pre-trained Resnet50 and VGG16 plus our own small CNN were tuned or trained on a balanced set of COVID-19 and pneumonia chest X-rays. An ensemble of the three types of CNN classifiers was applied to a test set of 33 unseen COVID-19 and 218 pneumonia cases. The overall accuracy was 91.24% with the true positive rate for COVID-19 of 0.7879 with 6.88% false positives for a true negative rate of 0.9312 and AUC of 0.94. </p><p> This preliminary study has flaws, most critically a lack of information about where in the disease process the COVID-19 cases were and the small data set size. More COVID-19 case images at good resolution will enable a better answer to the question of how useful chest X-rays can be for diagnosing COVID-19.</p>